Saputra et al., 2025 - Google Patents
Synthesis And Characterization of Insulin-MOF-5 Loaded into Cellulose Nanocrystalline-Based Dissolving Microneedle as Anti-Diabetic Delivery SystemSaputra et al., 2025
View PDF- Document ID
- 9531007671553922506
- Author
- Saputra M
- Nabila A
- Maulida F
- Ramadhani S
- Syafiq M
- Tarigan I
- Publication year
- Publication venue
- Journal of Medicinal and Chemical Sciences
External Links
Snippet
Diabetes mellitus (DM), as one of the global health problems, continues to increase annually. According to data from the International Diabetes Federation (IDF), in 2021, the number of people with diabetes mellitus in Indonesia reached 19.47 million and is projected …
- 229920002678 cellulose 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy | |
| Liu et al. | Fabrication of dissolving microneedles with thermal-responsive coating for NIR-triggered transdermal delivery of metformin on diabetic rats | |
| Wang et al. | Insulin-loaded silk fibroin microneedles as sustained release system | |
| Wu et al. | Assisted 3D printing of microneedle patches for minimally invasive glucose control in diabetes | |
| Luo et al. | Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery | |
| RU2719584C2 (en) | Glucose-responsive insulin delivery system using hypoxia-sensitive nanocomposites | |
| US20230364402A1 (en) | Core-shell microneedle devices and uses thereof | |
| CN109125912B (en) | 3D printing microneedle patch for intelligent blood sugar regulation and preparation method thereof | |
| Oh et al. | Fabrication of a PVA-Based hydrogel microneedle patch | |
| Volpatti et al. | Microgel encapsulated nanoparticles for glucose-responsive insulin delivery | |
| Yang et al. | Glucose-responsive insulin release: analysis of mechanisms, formulations, and evaluation criteria | |
| Yu et al. | Transdermal delivery of insulin with bioceramic composite microneedles fabricated by gelatin and hydroxyapatite | |
| Sun et al. | A theranostic microneedle array patch for integrated glycemia sensing and self-regulated release of insulin | |
| Erzengin et al. | In vitro and in vivo evaluation of 3D printed sodium alginate/polyethylene glycol scaffolds for sublingual delivery of insulin: Preparation, characterization, and pharmacokinetics | |
| Zong et al. | Glucose-responsive insulin microneedle patch based on phenylboronic acid for 1 diabetes treatment | |
| US11331277B2 (en) | H2O2-responsive nanoparticles and uses thereof | |
| Wang et al. | Microneedles with two-stage glucose-sensitive controlled release for long-term insulin delivery | |
| Lu et al. | Preparation of phenylboronic acid‐based glucose-responsive hydrogels and microneedles for regulated delivery of insulin | |
| Cao et al. | Sustained release of insulin from silk microneedles | |
| Saputra et al. | Synthesis And Characterization of Insulin-MOF-5 Loaded into Cellulose Nanocrystalline-Based Dissolving Microneedle as Anti-Diabetic Delivery System | |
| Wang et al. | Dual responsive block copolymer coated hollow mesoporous silica nanoparticles for glucose-mediated transcutaneous drug delivery | |
| Jia et al. | Silk fibroin/chitosan pH-sensitive controlled microneedles | |
| Jiang et al. | Thermosensitive microneedles capable of on demand insulin release for precise diabetes treatment | |
| Cai et al. | On-demand release of insulin using glucose-responsive chitosan-based three-compartment microspheres | |
| CN102961340B (en) | Nanoscale insulin and preparation method thereof |